Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma

Journal of Clinical Oncology

Volumn 28, Issue 9, 2010, Pages 1606-1610

  Hillengass, Jens ^a   Fechtner, Kerstin ^a   Weber, Marc André ^a   Bäuerle, Tobias ^a   Ayyaz, Sofia ^a   Heiss, Christiane ^a   Hielscher, Thomas ^a   Moehler, Thomas M ^a   Egerer, Gerlinde ^a   Neben, Kai ^a   Ho, Anthony D ^a   Kauczor, Hans Ulrich ^a   Delorme, Stefan ^a   Goldschmidt, Hartmut ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT; UNIVARIATE ANALYSIS; WHOLE BODY MRI; DISEASE COURSE; MIDDLE AGED; SURVIVAL; WHOLE BODY IMAGING;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; WHOLE BODY IMAGING;

EID: 77951937119     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.5356     Document Type: Article

References (31)

1. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. Br J Haematol 121:749-757, 2003
2. Dispenzieri A, Rajkumar SV, Gertz MA, et al: Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus statement. Mayo Clin Proc 82:323-341, 2007 (Pubitemid 46348934)
3. Kyle RA, Remstein ED, Therneau TM, et al: Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 356:2582-2590, 2007 (Pubitemid 46961003)
4. Weber DM, Dimopoulos MA, Moulopoulos LA, et al: Prognostic features of asymptomatic multiple myeloma. Br J Haematol 97:810-814, 1997 (Pubitemid 27321380)
5. Cesana C, Klersy C, Barbarano L, et al: Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. J Clin Oncol 20:1625-1634, 2002 (Pubitemid 34260544)
6. Dimopoulos M, Terpos E, Comenzo RL, et al: International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia 23:1545-1556, 2009
7. Walker R, Barlogie B, Haessler J, et al: Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications. J Clin Oncol 25: 1121-1128, 2007 (Pubitemid 46596765)
8. Johnson KM, Leavitt GD, Kayser HW: Totalbody MR imaging in as little as 18 seconds. Radiology 202:262-267, 1997
9. Bäuerle T, Hillengass J, Fechtner K, et al: The importance of whole body as compared with spinal magnetic resonance imaging in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. Radiology 252:477-485, 2009
10. Stäbler A, Baur A, Bartl R, et al: Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: Assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol 167:1029-1036, 1996 (Pubitemid 26322270)
11. Baur A, Stabler A, Nagel D, et al: Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon? Cancer 95: 1334-1345, 2002
12. Lausen B, Schumacher M: Maximally Selected Rank Statistics. Biometrics 48:73-85, 1992
13. Hothorn T, Lausen B: On the Exact Distribution of Maximally Selected Rank Statistics. Computional Statistics and Data Analysis 43:121-137, 2003 (Pubitemid 36715216)
14. Lausen B, Hothorn T: Optimally Selected Prognostic Factors. Biometrical Journal 2004:364-374, 2004
15. Lawless JF, Singhal K: Efficient screening of nonnormal regression models Biometrics 34:318-327, 1978
16. Ludwig H, Fruhwald F, Tscholakoff D, et al: Magnetic resonance imaging of the spine in multiple myeloma. Lancet 2:364-366, 1987 (Pubitemid 17125287)
17. Lecouvet FE, Vande Berg BC, Michaux L, et al: Stage III multiple myeloma: Clinical and prognostic value of spinal bone marrow MR imaging. Radiology 209:653-660, 1998
18. Moulopoulos LA, Gika D, Anagnostopoulos A, et al: Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma. Ann Oncol 16: 1824-1828, 2005
19. Moore SG, Dawson KL: Red and yellow marrow in the femur: Age-related changes in appearance at MR imaging. Radiology 175:219-223, 1990 (Pubitemid 20108569)
20. Ricci C, Cova M, Kang YS, et al: Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology 177:83-88, 1990 (Pubitemid 20317326)
21. Ghanem N, Lohrmann C, Engelhardt M, et al: Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 16:1005-1014, 2006
22. Baur-Melnyk A, Buhmann S, Becker C, et al: Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. AJR Am J Roentgenol 190:1097-1104, 2008 (Pubitemid 351571514)
23. Cavo M, Baccarani M, Gobbi M, et al: Prognostic value of bone marrow plasma cell infiltration in stage I multiple myeloma. Br J Haematol 55:683-690, 1983 (Pubitemid 14241288)
24. Berenson JR: Myeloma bone disease. Best Pract Res Clin Haematol 18:653-672, 2005
25. Edelstyn GA, Gillespie PJ, Grebbell FS: The radiological demonstration of osseous metastases: Experimental observations. Clin Radiol 18:158-162, 1967
26. Mahnken AH, Wildberger JE, Gehbauer G, et al: Multidetector CT of the spine in multiple myeloma: Comparison with MR imaging and radiography. AJR Am J Roentgenol 178:1429-1436, 2002 (Pubitemid 34547826)
27. Horger M, Claussen CD, Bross-Bach U, et al: Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: An alternative to conventional radiography. Eur J Radiol 54:289-297, 2005 (Pubitemid 40523623)
28. Durie BG, Waxman AD, D'Agnolo A, et al: Whole-body (18)F-FDG PET identifies high-risk myeloma. J Nucl Med 43:1457-1463, 2002 (Pubitemid 35285870)
29. Baur A, Bartl R, Pellengahr C, et al: Neovascularization of bone marrow in patients with diffuse multiple myeloma: A correlative study of magnetic resonance imaging and histopathologic findings. Cancer 101:2599-2604, 2004 (Pubitemid 39532290)
30. Hur J, Yoon CS, Ryu YH, et al: Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma. Acta Radiol 49:427-435, 2008 (Pubitemid 351598798)
31. Dinter DJ, Neff WK, Klaus J, et al: Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol 88:457-464, 2009